YPrime Commits to United Nations Global Compact, Pledging to Align its Sustainable Business Practices with UN Goals
17 déc. 2024 09h57 HE
|
Y-Prime, LLC
YPrime pledges to United Nations Global Compact, expanding its program of sustainable business practices.
Anti-Aging Market Expected to Reach USD 2.29 Billion by 2032, Growing at a CAGR of 7.6% From 2024-2032 | Introspective Market Research
12 déc. 2024 10h34 HE
|
Introspective Market Research
United States, New York, Dec. 12, 2024 (GLOBE NEWSWIRE) -- The Global Anti-Aging market is rising due to technological advancements in the genomics and biotechnology industry. The drive of the...
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
12 déc. 2024 07h30 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics Approach
Avextra Supports First Fully EU-Funded Psilocybin Therapy Study, Now Approved by EMA
12 déc. 2024 07h00 HE
|
Avextra Pharma GmbH
Exclusive Industry Role: Avextra is the industry partner in the first EU-funded project focused on psychedelic-assisted therapy for patients in palliative care suffering from depression, with a total...
Meningitis Treatment Market to Reach US$ 234.8 Million by 2034 Amid Advancements in Diagnostics and Vaccination Programs
05 déc. 2024 07h00 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Meningitis Treatment Market Outlook 2034: Analyzing Key Trends and Opportunities The global...
SoftServe Unveils New Gen AI Solution ‘Drug Discovery,’ Built with NVIDIA Blueprints at AWS re:Invent 2024
03 déc. 2024 13h31 HE
|
SoftServe
AUSTIN, Texas, Dec. 03, 2024 (GLOBE NEWSWIRE) -- SoftServe, a premier IT consulting and digital services provider, today announced the debut of its newest Generative AI (Gen AI) solution, Drug...
Alira Health Unveils 2024 Report on Antibody-Drug Conjugates Market
03 déc. 2024 09h00 HE
|
Alira Health
Gain comprehensive insights into the ADC market with the Alira Health 2024 Global Antibody-Drug Conjugates Report's in-depth analysis.
Smart Immune et CELLforCURE by SEQENS s'associent pour industrialiser la production des lots cliniques de SMART101
03 déc. 2024 00h00 HE
|
Smart Immune
COMMUNIQUÉ DE PRESSE | Paris, France - 3 décembre 2024 Smart Immune, société de biotechnologie en stade clinique, et CELLforCURE by SEQENS, entreprise de développement et de fabrication en...
Smart Immune and CELLforCURE by SEQENS Partner to Industrialize SMART101 Clinical Batches Manufacturing
03 déc. 2024 00h00 HE
|
Smart Immune
PRESS RELEASE | Paris, France – December 3, 2024 Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for...
CBIH Advocates for Cannabis Policy Reform at DEA Reclassification Hearing
02 déc. 2024 08h00 HE
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) proudly announces its active participation in today’s DEA meaningful hearing